BRSL heads into its July 28 earnings with options traders flashing the most defensive signal on record for this name, even as short sellers remain lightly positioned.
The options market is sending an unmistakable warning. The put/call ratio jumped to 0.99 this week — the highest reading of the past year — and is nearly three standard deviations above its 20-day average of 0.73. That z-score of 2.91 places the current demand for downside protection firmly in statistical outlier territory. The shift is abrupt: the PCR held in a narrow 0.68–0.72 band for most of May and early June before leaping to 0.99 over the past two sessions, suggesting a specific catalyst has triggered fresh hedging rather than a gradual drift in sentiment.
Short interest tells a notably calmer story. Bears hold 3.2% of the free float — up about 6% over the past month, but hardly a crowded position. Borrow costs have actually eased, falling 13% week-on-week to 0.45%, a low even by this stock's historically inexpensive standards. Availability is ample at 570%, meaning roughly five and a half shares remain available to borrow for every share already shorted. The lending market is loose. Short sellers are not pressing a conviction bet here; the defensive posture is coming entirely from the options desk.
The fundamental backdrop explains why options traders are reaching for cover. Brightstar Lottery issued weaker Q2 EBITDA guidance after a stumbling B2C launch and disappointing UK lottery performance. The bull case centres on Italy, where an expanded contract now covers iCasino, sports betting, and bingo — a meaningful slice of a roughly $6 billion online gaming market. Bears point to FX tailwinds potentially masking a deeper guidance problem, with full-year estimates at risk. The analyst community has spent the past six weeks trimming targets: multiple firms cut in mid-May, with Susquehanna taking its target from $21 to $15 while Stifel held its Buy but dropped to $19. The consensus mean target of $16.71 implies roughly 54% upside from the current $10.82 — a gap that reflects the Street's genuine uncertainty about whether the Italian expansion offsets near-term misses rather than a straightforward rerating opportunity. The EV/EBITDA of 4.75 and a P/E near 14 keep valuation from being the obvious problem; execution is. Peers offer mixed comfort: fell 10% on the week while and shed roughly 2%, suggesting some sector-level pressure rather than purely idiosyncratic pain for BRSL.
One institutional data point adds texture. Victory Capital added more than 5.5 million shares in the quarter to March, making it one of the more aggressive builders in the register. Citadel added nearly 2 million shares in the same period. Those moves sit against Samlyn Capital trimming by 580,000 and Solel Partners cutting by 1.4 million — a split that mirrors the broader bull-bear debate on whether the Italian contract and lottery fundamentals justify patience through a difficult transition year.
The last earnings print — May 12 — sent the stock down 14% the next day and 17% over the five-day window. With July 28 approaching and the PCR at its 52-week peak, the question is whether that post-results pattern or the Italian expansion thesis shapes the next move.
See the live data behind this article on ORTEX.
Open BRSL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
